AGÕæÈ˹ٷ½

STOCK TITAN

[S-8 POS] Inozyme Pharma, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-8 POS
Rhea-AI Filing Summary

Greif, Inc. (NYSE: GEF) has entered into a definitive agreement to divest its entire containerboard business—held through Greif Containerboard Solutions, LLC (GCS) and Box-Board Holding Corporation (BBH)—to Packaging Corporation of America (PCA) for $1.8 billion in cash, subject to customary adjustments. The transaction was executed on June 30, 2025 and disclosed via Form 8-K on July 1, 2025.

Under the Purchase and Sale Agreement, Greif Packaging LLC (the “Seller�) will first contribute all containerboard assets—mills, sheet feeder facilities, equipment and related items—to GCS. PCA will then acquire 100 % of the Seller’s equity interests in both GCS and BBH. Closing is conditioned on standard requirements, most notably the expiration or early termination of the Hart-Scott-Rodino (HSR) antitrust waiting period.

Outside Date & Termination: Either party may terminate if closing has not occurred by June 30, 2026, with up to two 90-day extensions available (one mutual, one at Greif’s option). Additional termination rights exist for mutual consent, non-appealable governmental prohibition, or uncured breaches of representations, warranties or covenants by either party.

The filing cautions investors not to rely solely on the representations and warranties within the agreement for factual determinations, noting that conditions may change over time. A related press release dated July 1, 2025 (Exhibit 99.1) announces the divestiture, and the full Agreement is furnished as Exhibit 10.1.

Strategic Implications: If completed, the sale will bring a substantial influx of cash and marks Greif’s exit from the containerboard segment, potentially reshaping its product portfolio toward remaining industrial packaging operations. However, completion risk remains until all regulatory and contractual conditions are met.

Greif, Inc. (NYSE: GEF) ha stipulato un accordo definitivo per cedere l'intero business del cartone ondulato—gestito tramite Greif Containerboard Solutions, LLC (GCS) e Box-Board Holding Corporation (BBH)—a Packaging Corporation of America (PCA) per 1,8 miliardi di dollari in contanti, soggetti a consueti aggiustamenti. La transazione è stata eseguita il 30 giugno 2025 e comunicata tramite il modulo 8-K il 1° luglio 2025.

In base all'accordo di compravendita, Greif Packaging LLC (il “Venditore�) trasferirà prima tutti gli asset relativi al cartone ondulato—cartiere, impianti di alimentazione fogli, attrezzature e beni correlati—a GCS. PCA acquisirà quindi il 100% delle partecipazioni azionarie del Venditore sia in GCS che in BBH. La chiusura è subordinata al rispetto dei requisiti standard, in particolare alla scadenza o alla risoluzione anticipata del periodo di attesa antitrust Hart-Scott-Rodino (HSR).

Data di scadenza e risoluzione: Ciascuna parte può recedere se la chiusura non avviene entro il 30 giugno 2026, con la possibilità di due proroghe di 90 giorni ciascuna (una congiunta e una a discrezione di Greif). Sono previsti ulteriori diritti di risoluzione per consenso reciproco, divieto governativo non appellabile o violazioni non sanate di dichiarazioni, garanzie o impegni da parte di entrambe le parti.

Il deposito invita gli investitori a non fare affidamento esclusivamente sulle dichiarazioni e garanzie contenute nell'accordo per determinazioni di fatto, sottolineando che le condizioni possono variare nel tempo. Un comunicato stampa del 1° luglio 2025 (Esibizione 99.1) annuncia la cessione, mentre l'intero accordo è fornito come Esibizione 10.1.

Implicazioni strategiche: Se completata, la vendita porterà un significativo afflusso di liquidità e segnerà l'uscita di Greif dal segmento del cartone ondulato, potenzialmente rimodellando il portafoglio prodotti verso le restanti attività di imballaggio industriale. Tuttavia, il rischio di completamento permane fino al soddisfacimento di tutte le condizioni regolamentari e contrattuali.

Greif, Inc. (NYSE: GEF) ha firmado un acuerdo definitivo para vender todo su negocio de cartón corrugado—mantenido a través de Greif Containerboard Solutions, LLC (GCS) y Box-Board Holding Corporation (BBH)—a Packaging Corporation of America (PCA) por 1,800 millones de dólares en efectivo, sujetos a ajustes habituales. La transacción se ejecutó el 30 de junio de 2025 y fue divulgada mediante el Formulario 8-K el 1 de julio de 2025.

Bajo el Acuerdo de Compra y Venta, Greif Packaging LLC (el “Vendedor�) primero aportará todos los activos de cartón corrugado—fábricas, instalaciones de alimentación de hojas, equipos y elementos relacionados—a GCS. Luego, PCA adquirirá el 100 % de las participaciones accionarias del Vendedor en GCS y BBH. El cierre está condicionado a requisitos estándar, principalmente a la expiración o terminación anticipada del período de espera antimonopolio Hart-Scott-Rodino (HSR).

Fecha límite y terminación: Cualquiera de las partes puede rescindir si el cierre no se realiza antes del 30 de junio de 2026, con hasta dos extensiones de 90 días disponibles (una mutua y otra a opción de Greif). Existen derechos adicionales para terminar por consentimiento mutuo, prohibición gubernamental no apelable o incumplimientos no subsanados de declaraciones, garantías o convenios por cualquiera de las partes.

La presentación advierte a los inversores que no se basen únicamente en las declaraciones y garantías del acuerdo para determinaciones de hechos, señalando que las condiciones pueden cambiar con el tiempo. Un comunicado de prensa fechado el 1 de julio de 2025 (Exhibición 99.1) anuncia la venta, y el acuerdo completo se presenta como Exhibición 10.1.

Implicaciones estratégicas: Si se completa, la venta generará una entrada sustancial de efectivo y marcará la salida de Greif del segmento de cartón corrugado, lo que podría reconfigurar su cartera de productos hacia las operaciones restantes de embalaje industrial. Sin embargo, el riesgo de cierre persiste hasta que se cumplan todas las condiciones regulatorias y contractuales.

Greif, Inc. (NYSE: GEF)ëŠ� 컨테ì´ë„ˆë³´ë“œ 사업 ì „ì²´ë¥� 매ê°í•˜ëŠ” 최종 계약ì� 체결했습니다—Greif Containerboard Solutions, LLC(GCS)와 Box-Board Holding Corporation(BBH)ì� 통해 보유í•� 사업으로â€�Packaging Corporation of America (PCA)ì—� 18ì–� 달러 현금, 관례ì ì¸ ì¡°ì • ì¡°ê±´ í•˜ì— ë§¤ê°í•©ë‹ˆë‹�. 거래ëŠ� 2025ë…� 6ì›� 30ì¼ì— 실행ë˜ì—ˆìœ¼ë©° 2025ë…� 7ì›� 1ì� Form 8-Kë¥� 통해 공시ë˜ì—ˆìŠµë‹ˆë‹�.

매매계약ì—� ë”°ë¼ Greif Packaging LLC(“íŒë§¤ìžâ€�)ëŠ� 먼저 모든 컨테ì´ë„ˆë³´ë“œ ìžì‚°â€”제지 공장, 시트 공급 시설, 장비 ë°� ê´€ë � í’ˆëª©â€”ì„ GCSì—� ì´ì „합니ë‹�. ì´í›„ PCAëŠ� íŒë§¤ìžì˜ GCS ë°� BBH ì§€ë¶� 100%ë¥� ì¸ìˆ˜í•©ë‹ˆë‹�. 거래 마ê°ì€ 표준 요건, 특히 Hart-Scott-Rodino(HSR) ë°˜ë…ì � 대기기ê°� 만료 ë˜ëŠ” 조기 종료ì—� ë”°ë¼ ë‹¬ë¼ì§‘니ë‹�.

ë§ˆê° ê¸°í•œ ë°� 계약 í•´ì§€: 마ê°ì� 2026ë…� 6ì›� 30ì¼ê¹Œì§€ ì´ë£¨ì–´ì§€ì§€ ì•Šì„ ê²½ìš° ì–´ëŠ í•œìª½ 당사ìžê°€ 계약ì� í•´ì§€í•� ìˆ� 있으ë©�, 최대 ë‘� ë²ˆì˜ 90ì� 연장(í•� ë²ˆì€ ìƒí˜¸, í•� ë²ˆì€ Greif ì„ íƒê¶�)ì� 가능합니다. ìƒí˜¸ í•©ì˜, ì •ë¶€ 금지 조치(항소 불가), ë˜ëŠ” ì–´ëŠ í•œìª½ì� 진술, ë³´ì¦, ì•½ì† ìœ„ë°˜ 미해ê²� ì‹� 추가 í•´ì§€ 권리가 있습니다.

공시ëŠ� 투ìžìžë“¤ì—게 계약 ë‚� 진술ê³� ë³´ì¦ë§Œìœ¼ë¡� 사실 íŒë‹¨ì� 하지 ë§� ê²ƒì„ ê²½ê³ í•˜ë©°, ì¡°ê±´ì� 시간ì� ì§€ë‚¨ì— ë”°ë¼ ë³€í•� ìˆ� 있ìŒì� 명시합니ë‹�. ê´€ë � ë³´ë„ìžë£Œ(2025ë…� 7ì›� 1ì�, Exhibit 99.1)ê°€ 매ê°ì� 알리ê³� ì „ì²´ 계약서는 Exhibit 10.1ë¡� 제공ë©ë‹ˆë‹�.

ì „ëžµì � ì˜ë¯¸: 거래가 완료ë˜ë©´ ìƒë‹¹í•� 현금 유입ì� ë°œìƒí•˜ë©°, Greifê°€ 컨테ì´ë„ˆë³´ë“œ 부문ì—ì„� ì² ìˆ˜í•¨ì„ ì˜ë¯¸í•� ë‚¨ì€ ì‚°ì—…ìš� í¬ìž¥ 사업 중심으로 제품 í¬íЏí´ë¦¬ì˜¤ê°€ 재편ë� 가능성ì� 있습니다. 다만 모든 규제 ë°� 계약 ì¡°ê±´ 충족 전까지ëŠ� 거래 완료 위험ì� 남아 있습니다.

Greif, Inc. (NYSE : GEF) a conclu un accord définitif pour céder l'intégralité de son activité carton ondulé—détenue via Greif Containerboard Solutions, LLC (GCS) et Box-Board Holding Corporation (BBH)—� Packaging Corporation of America (PCA) pour 1,8 milliard de dollars en espèces, sous réserve d'ajustements habituels. La transaction a été réalisée le 30 juin 2025 et divulguée via le formulaire 8-K le 1er juillet 2025.

Selon l'accord d'achat et de vente, Greif Packaging LLC (le « Vendeur ») transférera d'abord tous les actifs liés au carton ondulé—usines, installations d'alimentation en feuilles, équipements et éléments associés—� GCS. PCA acquérra ensuite 100 % des intérêts en capital du Vendeur dans GCS et BBH. La clôture est conditionnée au respect des exigences habituelles, notamment à l'expiration ou à la levée anticipée de la période d'attente antitrust Hart-Scott-Rodino (HSR).

Date limite et résiliation : Chaque partie peut résilier si la clôture n'a pas eu lieu avant le 30 juin 2026, avec jusqu'à deux prolongations de 90 jours (une mutuelle, une à l'option de Greif). Des droits de résiliation supplémentaires existent en cas de consentement mutuel, d'interdiction gouvernementale non susceptible d'appel ou de manquements non corrigés aux déclarations, garanties ou engagements par l'une ou l'autre des parties.

Le dépôt met en garde les investisseurs de ne pas se fier uniquement aux déclarations et garanties contenues dans l'accord pour des déterminations factuelles, soulignant que les conditions peuvent évoluer. Un communiqué de presse daté du 1er juillet 2025 (Exhibit 99.1) annonce la cession, et l'accord complet est fourni en Exhibit 10.1.

Implications stratégiques : Si elle est finalisée, la vente générera un afflux de liquidités important et marque la sortie de Greif du segment du carton ondulé, ce qui pourrait redéfinir son portefeuille de produits vers ses opérations restantes dans l'emballage industriel. Toutefois, le risque d'achèvement subsiste tant que toutes les conditions réglementaires et contractuelles ne sont pas remplies.

Greif, Inc. (NYSE: GEF) hat eine endgültige Vereinbarung zum Verkauf seines gesamten Containerboard-Geschäfts abgeschlossen—gehalten über Greif Containerboard Solutions, LLC (GCS) und Box-Board Holding Corporation (BBH)—an Packaging Corporation of America (PCA) ´Úü°ù 1,8 Milliarden US-Dollar in bar, vorbehaltlich üblicher Anpassungen. Die Transaktion wurde am 30. Juni 2025 durchgeführt und am 1. Juli 2025 via Formular 8-K bekanntgegeben.

Gemäß dem Kauf- und Verkaufsvertrag wird Greif Packaging LLC (der „Verkäufer�) zunächst alle Containerboard-Assets—Mühlen, Bogenbeschickungsanlagen, Ausrüstung und zugehörige Gegenstände—an GCS übertragen. Anschließend erwirbt PCA 100 % der Eigentumsanteile des Verkäufers an GCS und BBH. Der Abschluss ist an übliche Bedingungen geknüpft, insbesondere an die Ablauf- oder vorzeitige Beendigung der Hart-Scott-Rodino (HSR) Wettbewerbsaufsichtsfrist.

Außerkraftsetzungsdatum & Kündigung: Jede Partei kann kündigen, falls der Abschluss bis zum 30. Juni 2026 nicht erfolgt, mit bis zu zwei Verlängerungen von jeweils 90 Tagen (eine einvernehmlich, eine nach Wahl von Greif). Weitere Kündigungsrechte bestehen bei gegenseitigem Einvernehmen, unanfechtbarem behördlichen Verbot oder nicht behobenen Verstößen gegen Zusicherungen, Gewährleistungen oder Verpflichtungen einer Partei.

Die Einreichung warnt Investoren davor, sich ausschließlich auf die Zusicherungen und Gewährleistungen im Vertrag ´Úü°ù Tatsachenfeststellungen zu verlassen, da sich Bedingungen im Laufe der Zeit ändern können. Eine zugehörige Pressemitteilung vom 1. Juli 2025 (Anlage 99.1) kündigt die Veräußerung an, der vollständige Vertrag ist als Anlage 10.1 ²ú±ð¾±²µ±ð´Úü²µ³Ù.

Strategische Auswirkungen: Bei Abschluss bringt der Verkauf einen erheblichen Geldzufluss und markiert den Ausstieg von Greif aus dem Containerboard-Segment, was das Produktportfolio zugunsten der verbleibenden industriellen Verpackungsgeschäfte neu ausrichten könnte. Das Risiko des Abschlusses bleibt jedoch bestehen, bis alle regulatorischen und vertraglichen Bedingungen erfüllt sind.

Positive
  • $1.8 billion cash consideration represents a sizable liquidity event that can enhance Greif’s financial flexibility upon closing.
  • Divestiture allows strategic focus on core industrial packaging segments, potentially improving margin stability.
Negative
  • Completion risk: deal is subject to HSR approval and other closing conditions with an outside date more than a year away.
  • Greif will lose its containerboard revenue stream, reducing vertical integration and exposing the company to supplier market dynamics.

Insights

TL;DR: $1.8 billion divestiture provides major liquidity and portfolio refocus; closing still subject to HSR and other conditions.

The announced sale price equals a material infusion of capital relative to Greif’s market capitalization and could significantly strengthen the balance sheet once received. Divesting the containerboard business may improve margin consistency by removing a cyclical segment. Because proceeds are cash, leverage ratios should improve immediately at closing. Key risks are regulatory approval and a long outside date, which may delay benefit realisation. Overall, the agreement is financially accretive upon completion and signals a strategic shift toward core industrial packaging lines.

TL;DR: Transaction reshapes Greif’s product mix; execution and revenue-loss risks temper enthusiasm.

Greif exits a vertically integrated containerboard platform, potentially relinquishing supply-chain advantages and a revenue source. PCA solidifies its mill footprint, which may increase competitive pressure on Greif’s remaining packaging products. Operational separation and customer transition require careful management. Until closing, Greif must operate the business under customary covenants, and failure to secure antitrust clearance could nullify the deal. Impact is strategically significant but contingent on timely close.

Greif, Inc. (NYSE: GEF) ha stipulato un accordo definitivo per cedere l'intero business del cartone ondulato—gestito tramite Greif Containerboard Solutions, LLC (GCS) e Box-Board Holding Corporation (BBH)—a Packaging Corporation of America (PCA) per 1,8 miliardi di dollari in contanti, soggetti a consueti aggiustamenti. La transazione è stata eseguita il 30 giugno 2025 e comunicata tramite il modulo 8-K il 1° luglio 2025.

In base all'accordo di compravendita, Greif Packaging LLC (il “Venditore�) trasferirà prima tutti gli asset relativi al cartone ondulato—cartiere, impianti di alimentazione fogli, attrezzature e beni correlati—a GCS. PCA acquisirà quindi il 100% delle partecipazioni azionarie del Venditore sia in GCS che in BBH. La chiusura è subordinata al rispetto dei requisiti standard, in particolare alla scadenza o alla risoluzione anticipata del periodo di attesa antitrust Hart-Scott-Rodino (HSR).

Data di scadenza e risoluzione: Ciascuna parte può recedere se la chiusura non avviene entro il 30 giugno 2026, con la possibilità di due proroghe di 90 giorni ciascuna (una congiunta e una a discrezione di Greif). Sono previsti ulteriori diritti di risoluzione per consenso reciproco, divieto governativo non appellabile o violazioni non sanate di dichiarazioni, garanzie o impegni da parte di entrambe le parti.

Il deposito invita gli investitori a non fare affidamento esclusivamente sulle dichiarazioni e garanzie contenute nell'accordo per determinazioni di fatto, sottolineando che le condizioni possono variare nel tempo. Un comunicato stampa del 1° luglio 2025 (Esibizione 99.1) annuncia la cessione, mentre l'intero accordo è fornito come Esibizione 10.1.

Implicazioni strategiche: Se completata, la vendita porterà un significativo afflusso di liquidità e segnerà l'uscita di Greif dal segmento del cartone ondulato, potenzialmente rimodellando il portafoglio prodotti verso le restanti attività di imballaggio industriale. Tuttavia, il rischio di completamento permane fino al soddisfacimento di tutte le condizioni regolamentari e contrattuali.

Greif, Inc. (NYSE: GEF) ha firmado un acuerdo definitivo para vender todo su negocio de cartón corrugado—mantenido a través de Greif Containerboard Solutions, LLC (GCS) y Box-Board Holding Corporation (BBH)—a Packaging Corporation of America (PCA) por 1,800 millones de dólares en efectivo, sujetos a ajustes habituales. La transacción se ejecutó el 30 de junio de 2025 y fue divulgada mediante el Formulario 8-K el 1 de julio de 2025.

Bajo el Acuerdo de Compra y Venta, Greif Packaging LLC (el “Vendedor�) primero aportará todos los activos de cartón corrugado—fábricas, instalaciones de alimentación de hojas, equipos y elementos relacionados—a GCS. Luego, PCA adquirirá el 100 % de las participaciones accionarias del Vendedor en GCS y BBH. El cierre está condicionado a requisitos estándar, principalmente a la expiración o terminación anticipada del período de espera antimonopolio Hart-Scott-Rodino (HSR).

Fecha límite y terminación: Cualquiera de las partes puede rescindir si el cierre no se realiza antes del 30 de junio de 2026, con hasta dos extensiones de 90 días disponibles (una mutua y otra a opción de Greif). Existen derechos adicionales para terminar por consentimiento mutuo, prohibición gubernamental no apelable o incumplimientos no subsanados de declaraciones, garantías o convenios por cualquiera de las partes.

La presentación advierte a los inversores que no se basen únicamente en las declaraciones y garantías del acuerdo para determinaciones de hechos, señalando que las condiciones pueden cambiar con el tiempo. Un comunicado de prensa fechado el 1 de julio de 2025 (Exhibición 99.1) anuncia la venta, y el acuerdo completo se presenta como Exhibición 10.1.

Implicaciones estratégicas: Si se completa, la venta generará una entrada sustancial de efectivo y marcará la salida de Greif del segmento de cartón corrugado, lo que podría reconfigurar su cartera de productos hacia las operaciones restantes de embalaje industrial. Sin embargo, el riesgo de cierre persiste hasta que se cumplan todas las condiciones regulatorias y contractuales.

Greif, Inc. (NYSE: GEF)ëŠ� 컨테ì´ë„ˆë³´ë“œ 사업 ì „ì²´ë¥� 매ê°í•˜ëŠ” 최종 계약ì� 체결했습니다—Greif Containerboard Solutions, LLC(GCS)와 Box-Board Holding Corporation(BBH)ì� 통해 보유í•� 사업으로â€�Packaging Corporation of America (PCA)ì—� 18ì–� 달러 현금, 관례ì ì¸ ì¡°ì • ì¡°ê±´ í•˜ì— ë§¤ê°í•©ë‹ˆë‹�. 거래ëŠ� 2025ë…� 6ì›� 30ì¼ì— 실행ë˜ì—ˆìœ¼ë©° 2025ë…� 7ì›� 1ì� Form 8-Kë¥� 통해 공시ë˜ì—ˆìŠµë‹ˆë‹�.

매매계약ì—� ë”°ë¼ Greif Packaging LLC(“íŒë§¤ìžâ€�)ëŠ� 먼저 모든 컨테ì´ë„ˆë³´ë“œ ìžì‚°â€”제지 공장, 시트 공급 시설, 장비 ë°� ê´€ë � í’ˆëª©â€”ì„ GCSì—� ì´ì „합니ë‹�. ì´í›„ PCAëŠ� íŒë§¤ìžì˜ GCS ë°� BBH ì§€ë¶� 100%ë¥� ì¸ìˆ˜í•©ë‹ˆë‹�. 거래 마ê°ì€ 표준 요건, 특히 Hart-Scott-Rodino(HSR) ë°˜ë…ì � 대기기ê°� 만료 ë˜ëŠ” 조기 종료ì—� ë”°ë¼ ë‹¬ë¼ì§‘니ë‹�.

ë§ˆê° ê¸°í•œ ë°� 계약 í•´ì§€: 마ê°ì� 2026ë…� 6ì›� 30ì¼ê¹Œì§€ ì´ë£¨ì–´ì§€ì§€ ì•Šì„ ê²½ìš° ì–´ëŠ í•œìª½ 당사ìžê°€ 계약ì� í•´ì§€í•� ìˆ� 있으ë©�, 최대 ë‘� ë²ˆì˜ 90ì� 연장(í•� ë²ˆì€ ìƒí˜¸, í•� ë²ˆì€ Greif ì„ íƒê¶�)ì� 가능합니다. ìƒí˜¸ í•©ì˜, ì •ë¶€ 금지 조치(항소 불가), ë˜ëŠ” ì–´ëŠ í•œìª½ì� 진술, ë³´ì¦, ì•½ì† ìœ„ë°˜ 미해ê²� ì‹� 추가 í•´ì§€ 권리가 있습니다.

공시ëŠ� 투ìžìžë“¤ì—게 계약 ë‚� 진술ê³� ë³´ì¦ë§Œìœ¼ë¡� 사실 íŒë‹¨ì� 하지 ë§� ê²ƒì„ ê²½ê³ í•˜ë©°, ì¡°ê±´ì� 시간ì� ì§€ë‚¨ì— ë”°ë¼ ë³€í•� ìˆ� 있ìŒì� 명시합니ë‹�. ê´€ë � ë³´ë„ìžë£Œ(2025ë…� 7ì›� 1ì�, Exhibit 99.1)ê°€ 매ê°ì� 알리ê³� ì „ì²´ 계약서는 Exhibit 10.1ë¡� 제공ë©ë‹ˆë‹�.

ì „ëžµì � ì˜ë¯¸: 거래가 완료ë˜ë©´ ìƒë‹¹í•� 현금 유입ì� ë°œìƒí•˜ë©°, Greifê°€ 컨테ì´ë„ˆë³´ë“œ 부문ì—ì„� ì² ìˆ˜í•¨ì„ ì˜ë¯¸í•� ë‚¨ì€ ì‚°ì—…ìš� í¬ìž¥ 사업 중심으로 제품 í¬íЏí´ë¦¬ì˜¤ê°€ 재편ë� 가능성ì� 있습니다. 다만 모든 규제 ë°� 계약 ì¡°ê±´ 충족 전까지ëŠ� 거래 완료 위험ì� 남아 있습니다.

Greif, Inc. (NYSE : GEF) a conclu un accord définitif pour céder l'intégralité de son activité carton ondulé—détenue via Greif Containerboard Solutions, LLC (GCS) et Box-Board Holding Corporation (BBH)—� Packaging Corporation of America (PCA) pour 1,8 milliard de dollars en espèces, sous réserve d'ajustements habituels. La transaction a été réalisée le 30 juin 2025 et divulguée via le formulaire 8-K le 1er juillet 2025.

Selon l'accord d'achat et de vente, Greif Packaging LLC (le « Vendeur ») transférera d'abord tous les actifs liés au carton ondulé—usines, installations d'alimentation en feuilles, équipements et éléments associés—� GCS. PCA acquérra ensuite 100 % des intérêts en capital du Vendeur dans GCS et BBH. La clôture est conditionnée au respect des exigences habituelles, notamment à l'expiration ou à la levée anticipée de la période d'attente antitrust Hart-Scott-Rodino (HSR).

Date limite et résiliation : Chaque partie peut résilier si la clôture n'a pas eu lieu avant le 30 juin 2026, avec jusqu'à deux prolongations de 90 jours (une mutuelle, une à l'option de Greif). Des droits de résiliation supplémentaires existent en cas de consentement mutuel, d'interdiction gouvernementale non susceptible d'appel ou de manquements non corrigés aux déclarations, garanties ou engagements par l'une ou l'autre des parties.

Le dépôt met en garde les investisseurs de ne pas se fier uniquement aux déclarations et garanties contenues dans l'accord pour des déterminations factuelles, soulignant que les conditions peuvent évoluer. Un communiqué de presse daté du 1er juillet 2025 (Exhibit 99.1) annonce la cession, et l'accord complet est fourni en Exhibit 10.1.

Implications stratégiques : Si elle est finalisée, la vente générera un afflux de liquidités important et marque la sortie de Greif du segment du carton ondulé, ce qui pourrait redéfinir son portefeuille de produits vers ses opérations restantes dans l'emballage industriel. Toutefois, le risque d'achèvement subsiste tant que toutes les conditions réglementaires et contractuelles ne sont pas remplies.

Greif, Inc. (NYSE: GEF) hat eine endgültige Vereinbarung zum Verkauf seines gesamten Containerboard-Geschäfts abgeschlossen—gehalten über Greif Containerboard Solutions, LLC (GCS) und Box-Board Holding Corporation (BBH)—an Packaging Corporation of America (PCA) ´Úü°ù 1,8 Milliarden US-Dollar in bar, vorbehaltlich üblicher Anpassungen. Die Transaktion wurde am 30. Juni 2025 durchgeführt und am 1. Juli 2025 via Formular 8-K bekanntgegeben.

Gemäß dem Kauf- und Verkaufsvertrag wird Greif Packaging LLC (der „Verkäufer�) zunächst alle Containerboard-Assets—Mühlen, Bogenbeschickungsanlagen, Ausrüstung und zugehörige Gegenstände—an GCS übertragen. Anschließend erwirbt PCA 100 % der Eigentumsanteile des Verkäufers an GCS und BBH. Der Abschluss ist an übliche Bedingungen geknüpft, insbesondere an die Ablauf- oder vorzeitige Beendigung der Hart-Scott-Rodino (HSR) Wettbewerbsaufsichtsfrist.

Außerkraftsetzungsdatum & Kündigung: Jede Partei kann kündigen, falls der Abschluss bis zum 30. Juni 2026 nicht erfolgt, mit bis zu zwei Verlängerungen von jeweils 90 Tagen (eine einvernehmlich, eine nach Wahl von Greif). Weitere Kündigungsrechte bestehen bei gegenseitigem Einvernehmen, unanfechtbarem behördlichen Verbot oder nicht behobenen Verstößen gegen Zusicherungen, Gewährleistungen oder Verpflichtungen einer Partei.

Die Einreichung warnt Investoren davor, sich ausschließlich auf die Zusicherungen und Gewährleistungen im Vertrag ´Úü°ù Tatsachenfeststellungen zu verlassen, da sich Bedingungen im Laufe der Zeit ändern können. Eine zugehörige Pressemitteilung vom 1. Juli 2025 (Anlage 99.1) kündigt die Veräußerung an, der vollständige Vertrag ist als Anlage 10.1 ²ú±ð¾±²µ±ð´Úü²µ³Ù.

Strategische Auswirkungen: Bei Abschluss bringt der Verkauf einen erheblichen Geldzufluss und markiert den Ausstieg von Greif aus dem Containerboard-Segment, was das Produktportfolio zugunsten der verbleibenden industriellen Verpackungsgeschäfte neu ausrichten könnte. Das Risiko des Abschlusses bleibt jedoch bestehen, bis alle regulatorischen und vertraglichen Bedingungen erfüllt sind.

As filed with the Securities and Exchange Commission on July 1, 2025

Registration No. 333-240146

Registration No. 333-254685

Registration No. 333-263586

Registration No. 333-270733

Registration No. 333-277839

Registration No. 333-285687

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1 TO

FORM S-8 REGISTRATION STATEMENT No. 333-240146

FORM S-8 REGISTRATION STATEMENT No. 333-254685

FORM S-8 REGISTRATION STATEMENT No. 333-263586

FORM S-8 REGISTRATION STATEMENT No. 333-270733

FORM S-8 REGISTRATION STATEMENT No. 333-277839

FORM S-8 REGISTRATION STATEMENT No. 333-285687

UNDER

THE SECURITIES ACT OF 1933

 

 

INOZYME PHARMA, INC.

(Exact Name of Registrant As Specified In Its Charter)

 

 

 

Delaware   38-4024528
(State or other jurisdiction
of incorporation or organization)
  (I.R.S. Employer
Identification No.)

321 Summer Street

Suite 400

Boston, Massachusetts

  02210
(Address of Principal Executive Offices)   (Zip Code)

Amended and Restated 2017 Equity Incentive Plan, as amended

2020 Stock Incentive Plan

2020 Employee Stock Purchase Plan

2023 Inducement Stock Incentive Plan

(Full titles of the plans)

 

 

G. Eric Davis

President

Inozyme Pharma, Inc.

321 Summer Street

Suite 400

Boston, Massachusetts, 02210

(Name and address of agent for service)

(857) 330-4340

(Telephone number, including area code, of agent for service)

Copies to:

Jamie Leigh, Esq.

Ben Beerle, Esq.

Chadwick Mills, Esq.

Siana Lowrey, Esq.

Cooley LLP

3 Embarcadero Center

20th Floor

San Francisco, CA 94111

(415) 693-2000

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 
 


EXPLANATORY NOTE

This Post-Effective Amendment No. 1 relates to the following Registration Statements on Form S-8 (each a “Registration Statement” and collectively, the “Registration Statements”), filed with the Securities and Exchange Commission (the “SEC”) by Inozyme Pharma, Inc., a Delaware corporation (the “Registrant”) and is being filed to deregister any and all securities that remain unsold or otherwise unissued as of the date hereunder under such Registration Statements:

 

   

Registration Statement No. 333-240146, registering (i) 2,078,405 shares of the Registrant’s common stock, par value $0.0001 per share (“Common Stock”), issuable under the Inozyme Pharma, Inc. Amended and Restated 2017 Equity Incentive Plan, as amended; (ii) 2,014,380 shares of Common Stock issuable under the Inozyme Pharma, Inc. 2020 Stock Incentive Plan (the “2020 Incentive Plan”) and (iii) 198,539 shares of Common Stock issuable under the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan (the “ESPP”), filed with the SEC on July 28, 2020;

 

   

Registration Statement No. 333-254685, registering an additional (i) 935,398 shares of Common Stock issuable under the 2020 Incentive Plan and (ii) 233,849 shares of Common Stock issuable under the ESPP filed with the SEC on March 25, 2021;

 

   

Registration Statement No. 333-263586, registering an additional (i) 946,749 shares of Common Stock issuable under the 2020 Incentive Plan and (ii) 236,687 shares of Common Stock issuable under the ESPP, filed with the SEC on March 15, 2022;

 

   

Registration Statement No. 333-270733, registering (i) an additional 1,615,774 shares of Common Stock issuable under the 2020 Incentive Plan; (ii) an additional 397,079 shares of Common Stock issuable under the ESPP and (iii) 1,000,000 shares of Common Stock issuable under the Inozyme Pharma, Inc. 2023 Inducement Stock Incentive Plan filed with the SEC on March 22, 2023;

 

   

Registration Statement No. 333-277839, registering an additional (i) 2,470,750 shares of Common Stock issuable under the 2020 Incentive Plan and (ii) 397,079 shares of Common Stock issuable under the ESPP, filed with the SEC on March 12, 2024; and

 

   

Registration Statement No. 333-285687, registering an additional (i) 2,569,607 shares of Common Stock issuable under the 2020 Incentive Plan and (ii) 397,079 shares of Common Stock issuable under the ESPP, filed with the SEC on March 10, 2025.

On May 16, 2025, the Registrant entered into that certain Agreement and Plan of Merger (the “Merger Agreement”) with BioMarin Pharmaceutical Inc., a Delaware corporation (“Parent”), and Incline Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”). Pursuant to the Merger Agreement, on July 1, 2025, Merger Sub merged with and into the Registrant with the Registrant surviving the merger as a wholly-owned subsidiary of Parent (the “Merger”).

As a result of the Merger, the Registrant has terminated any and all of the offerings and sales of the Registrant’s securities pursuant to the Registration Statements. In accordance with the undertakings made by the Registrant in the Registration Statements to remove from registration, by means of a post-effective amendment, any securities that had been registered for issuance under the Registration Statements but remain unsold at the termination of the offerings, the Registrant hereby removes and withdraws from registration any and all securities registered pursuant to the Registration Statements that remain unsold as of the date hereof, and each Registration Statement is hereby amended, as appropriate, to reflect the deregistration of such securities, and the Registrant hereby terminates the effectiveness of the Registration Statements.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments No. 1 to the Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Rafael, California, on July 1, 2025.

 

Inozyme Pharma, Inc.

By:   /s/ G. Eric Davis

Name:

 

G. Eric Davis

Title:

 

President

No other person is required to sign these Post-Effective Amendments to the Registration Statements in reliance on Rule 478 of the Securities Act of 1933, as amended.

FAQ

What did Greif (GEF) announce in its July 1, 2025 Form 8-K?

Greif disclosed a definitive agreement to sell Greif Containerboard Solutions, LLC and Box-Board Holding Corporation to Packaging Corporation of America for $1.8 billion.

Who is buying Greif’s containerboard business and for how much?

Packaging Corporation of America (PCA) will acquire the business for $1.8 billion in cash, subject to adjustments.

What conditions must be met before the Greif-PCA transaction closes?

Key conditions include expiration or early termination of the Hart-Scott-Rodino antitrust waiting period plus other customary closing requirements.

When is the latest date the deal can close before either party may terminate?

Either party can terminate if closing has not occurred by June 30, 2026, with up to two 90-day extensions possible.

Where can investors find the full text of the sale agreement?

The complete Purchase and Sale Agreement is filed as Exhibit 10.1 to the July 1, 2025 Form 8-K.

Did Greif issue a press release about the divestiture?

Yes. The press release dated July 1, 2025 is furnished as Exhibit 99.1 in the filing.
Inozyme Pharma, Inc.

NASDAQ:INZY

INZY Rankings

INZY Latest News

INZY Latest SEC Filings

INZY Stock Data

257.60M
63.15M
1.26%
94.29%
5.24%
Biotechnology
Pharmaceutical Preparations
United States
BOSTON